US FDA sets up board to oversee drug exclusivity determinations
Oct 16 (Reuters) — The US FDA's drug evaluation department said on Friday it has formed a board to oversee and advise on exclusivity determinations made by the department, aiming to improve clarity and consistency of those decisions. Here are more details: FDA-granted exclusivity rewards innovation by giving newly appr